Baxter International Inc. (BAX)
After hours:
| Previous close | 36.91 |
| Open | 37.23 |
| Bid | 36.74 x 1000 |
| Ask | 36.94 x 900 |
| Day's range | 36.51 - 37.43 |
| 52-week range | 31.01 - 50.21 |
| Volume | |
| Avg. volume | 3,759,508 |
| Market cap | 18.798B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.16 (3.14%) |
| Ex-dividend date | 29 Feb 2024 |
| 1y target est | N/A |
- Business Wire
Baxter Reports First-Quarter 2024 Results
DEERFIELD, Ill., May 02, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2024.
- Business Wire
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.
DEERFIELD, Ill., April 11, 2024--Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, announced the continued expansion of its Pharmaceuticals portfolio with five injectable product launches in the U.S.
- Business Wire
Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors
DEERFIELD, Ill., April 10, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2024 financial results on Thursday, May 2, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I215737 to pre-register for the call and receive the call information.
